Search Videos and More
Pancreatic Cancer: Study Finds Most Early Staging Inaccurate
Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new Cedars-Sinai Cancer study published in the peer-reviewed journal JAMA.Scientific Stunt Double: How a Molecular Twin Is Changing Cancer Treatment, Research
When advanced technology and data from patients’ individual cells join forces, they can enormously expand what we know about cancer and how to treat it.Improving Prostate Cancer Screening for Transgender Women
A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.Cedars-Sinai Guerin Children’s Expert Reelected to Leadership Position of Pediatric Oncology Organization
Leo Mascarenhas, MD, MS, Continues Chairing Key Committee for Largest Research Organization Dedicated to Children With CancerLA Symposium in Reconstructive Plastic Surgery
Saturday, June 1, 2024, 8:00 AM - Sunday, June 2, 2024, 4:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CACedars-Sinai Cancer’s Blood and Marrow Transplant Patients Experience Superior Outcomes
Allogeneic transplants use blood stem cells from donors’ bone marrow to treat patients with blood and bone marrow diseases. The Cedars-Sinai team performs more than 40 such transplants each year.A Clinic for Ovarian Cancer ‘Previvors’
Cedars-Sinai Cancer’s One-Stop Option Helps BRCA1- and BRCA2-Positive Patients Manage Fertility, RiskFaculty Publications March 28-April 4
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published March 28-April 4.2024 Urology for the Primary Care Provider: Back to the Basics
Saturday, April 13, 2024, 8:00 AM - 12:10 PM PST, Online, Los Angeles, CAPediatric Cancer Expert Explains New Options for Children With Sarcomas
Q&A With Cedars-Sinai Guerin Children’s Pediatric Hematologist-Oncologist Leo Mascarenhas, MD, MSCedars-Sinai Cancer Releases 2024 Annual Report
The 2024 Cedars-Sinai Cancer Annual Report is now accessible. By harnessing the collective expertise of top cancer researchers and leveraging leading-edge Al technology, Cedars-Sinai Cancer is transforming cancer research and patient care through improved screening, innovative treatments and community outreach initiatives.Building a Diverse Pool of Leaders in Cancer Care and Research
Cedars-Sinai Cancer provides an equitable and inclusive future in cancer research and clinical care for a diverse population by targeting every level of learner—from high school students through senior faculty.